NCT04660266

Brief Summary

The purpose of the study: Validation of the use of intentional ultrasound examination, which includes Doppler and elastography for the diagnosis of obstructive venous disease of the liver within 21 days after bone marrow transplantation. Protocol: Patients who are planned for a bone marrow transplantaion will be recruited for the study by the staff of the Transplant Department. Inclusion criteria: Patients over the age of 18 before a bone marrow transplantation. Eligibility criteria: Transplanted under 18 years of age Research protocol: After informed consent, patients will undergo an ultrasound examination before the transplant. After 14 days and again after 21 days patients will undergo two more US exams, If there is a change in their clinical condition the patients will undergo additional examination accordingly. At the same time on the 14th and 21st day a clinical evaluation will be performed by the clinical physician in the transplant department based on clinical criteria of European Blood and Brain Transplant Association (EBMT). The results of the clinical evaluation and blood test results will be collected. Patients will be divided into two groups:

  • Control group: Patients who did not develop VOD( veno occlusive disease ) during 21 days.
  • Study group: Patients who developed VOD during 21 days. All ultrasound examination data will be compared between the two groups in In addition will be collected:
  • Demographics - age, sex.
  • Background diseases including heart and liver diseases.
  • Basic disease as a transplantation cause. All data will be collected anonymously and coded separately.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

December 9, 2020

Status Verified

December 1, 2020

Enrollment Period

1.8 years

First QC Date

November 18, 2020

Last Update Submit

December 6, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy of liver ultrasound in predicting VOD

    ultrasound results inculding gray scale , doppler and elastography will be compared to the clinical diagnosis of VOD the diagnosis of VOD will be performed according to the Europian Society for Blood and Marrow transplantation revised criteria 1. presence of ascites yes/no 2. liver enlagement more than 17 cm 3. Bilirubin \>2 mg/dl

    21 days

Study Arms (1)

all cohort

OTHER
Diagnostic Test: Liver Ultrasound

Interventions

Liver UltrasoundDIAGNOSTIC_TEST

liver ultrasound examination, including gray-scale and seven Doppler examination

all cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over the age of 18 before a bone marrow transplantation.

You may not qualify if:

  • Transplanted under 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Medical Center

Haifa, Israek, Israel

Location

Related Links

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: liver evaluation by US before, 14 days and 21 days after bone marrow transplantation, in the purpose to predict the appearance of Veno occlusive disease.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2020

First Posted

December 9, 2020

Study Start

December 1, 2020

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

December 9, 2020

Record last verified: 2020-12

Locations